MarketPeel
Insider Trading Intelligence
Pricing
…
GW

Gregory M. Weinhoff

CNTA
CHIEF FINANCIAL OFFICER · CENTESSA PHARMACEUTICALS PLC · CIK 0001400975
FILING MIX · LIFETIME29%/71%
BUYS
21
SELLS
51
TOTAL VALUE
$8.32M
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
0
AVG SELL PX
$16.19
TRADE KIND
SHOWING 72 / 72
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizons · 25 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gregory M. Weinhoff, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+23.81%+3.05%-0.08%+3.13%+4.17%—
14d21+28.57%+3.43%-0.32%+3.75%+2.03%—
30d21+33.33%+9.17%+2.78%+6.39%-1.02%—
60d21+33.33%+11.81%+5.12%+5.52%+2.27%—
90d21+33.33%+15.30%+6.12%+9.18%+4.33%—
180d21(3 pending)+33.33%+19.46%+8.07%+11.39%+4.09%—
1y21(4 pending)+0.00%+70.96%+17.55%+53.41%+38.10%—
2y21(18 pending)+0.00%+172.06%+43.34%+128.72%+232.39%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNTA · 0 shares · as of Jun 24, 2026
0239,745479,491719,236958,98120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 21 buys / 51 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
100,000——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
319,660——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
584,321——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
123,000——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
230,000——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
125,000——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
65,925——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
31,002——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
23,998——31,002Mar 26, 2026Mar 26, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
23,998$30.00$719.9K65,925Mar 26, 2026Mar 26, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
23,998$3.85$92.4K89,923Mar 26, 2026Mar 26, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
11,943$27.16$324.3K65,925Mar 13, 2026Mar 13, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
61,253$26.17$1.60M77,868Mar 13, 2026Mar 13, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
31,000——139,121Feb 2, 2026Feb 3, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
123,000——123,000Feb 2, 2026Feb 3, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
14,158$24.57$347.9K108,121Feb 1, 2026Feb 3, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K132,279Jul 25, 2025Jul 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——55,000Jul 25, 2025Jul 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$15.56$155.6K122,279Jul 25, 2025Jul 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——65,000Jun 25, 2025Jun 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K132,279Jun 25, 2025Jun 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$13.86$138.6K122,279Jun 25, 2025Jun 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$12.82$128.2K122,279May 27, 2025May 27, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——75,000May 27, 2025May 27, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K132,279May 27, 2025May 27, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
11,742$13.61$159.9K122,279Apr 25, 2025Apr 25, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——85,000Mar 25, 2025Mar 26, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$16.34$163.4K134,021Mar 25, 2025Mar 26, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K144,021Mar 25, 2025Mar 26, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
11,494$15.25$175.3K134,021Feb 25, 2025Feb 26, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
100,000——100,000Feb 3, 2025Feb 4, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
14,267$16.92$241.4K145,515Feb 1, 2025Feb 4, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
11,742$16.47$193.4K159,782Jan 27, 2025Jan 28, 2025 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
11,742$16.35$192.0K171,524Dec 31, 2024Dec 31, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$17.04$170.4K183,266Dec 26, 2024Dec 26, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K193,266Dec 26, 2024Dec 26, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——95,000Dec 26, 2024Dec 26, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
10,000$3.85$38.5K193,266Nov 25, 2024Nov 27, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
10,000$17.66$176.6K183,266Nov 25, 2024Nov 27, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
10,000——105,000Nov 25, 2024Nov 27, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
11,742$15.38$180.6K183,266Oct 25, 2024Oct 25, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
11,742$15.79$185.4K195,008Sep 30, 2024Oct 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
16,619$15.69$260.7K206,750Sep 25, 2024Sep 27, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
30,000——584,321Sep 10, 2024Sep 12, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
30,000$17.00$510.0K223,369Sep 10, 2024Sep 12, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
30,000$5.84$175.2K253,369Sep 10, 2024Sep 12, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
25,000$15.00$375.0K223,369Sep 9, 2024Sep 9, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Business Officer
25,000$5.84$146.0K248,369Sep 9, 2024Sep 9, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
25,000——614,321Sep 9, 2024Sep 9, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
17,802$12.29$218.8K223,369Aug 23, 2024Aug 23, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE10b5-1
10b5-1 plan
12,198$12.17$148.4K241,171Aug 22, 2024Aug 23, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Business Officer
11,742$9.03$106.0K253,369Jun 30, 2024Jul 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,742$11.30$132.7K265,111Mar 31, 2024Apr 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,494$8.19$94.1K276,853Feb 1, 2024Feb 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
125,000——125,000Feb 1, 2024Feb 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
31,250——288,347Feb 1, 2024Feb 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,742$7.96$93.5K257,097Dec 31, 2023Jan 2, 2024 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,742$6.47$76.0K268,839Sep 30, 2023Oct 3, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,742$5.90$69.3K280,581Jun 30, 2023Jul 3, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
8,292$3.90$32.3K292,323Mar 31, 2023Apr 4, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
115,000——115,000Feb 1, 2023Feb 3, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
77,200——300,615Feb 1, 2023Feb 3, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
5,303$3.10$16.4K234,697Dec 31, 2022Jan 4, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
4,901$3.95$19.4K231,099Oct 3, 2022Oct 4, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
4,000$4.07$16.3K236,000Sep 30, 2022Oct 4, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
Chief Financial Officer
11,282$4.25$47.9K228,718Sep 30, 2022Jan 13, 2023 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
230,000——240,000Jul 1, 2022Jul 6, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
230,000——230,000Feb 1, 2022Feb 3, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
Chief Financial Officer
10,000$20.00$200.0K10,000Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALEGRANT
Gift
319,660——639,321Apr 8, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Gift
319,660——319,660Apr 8, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
958,981——958,981Mar 4, 2021Jun 4, 2021 ↗View →
Other insiders · CNTA
Loading peer insiders…
About this filer
CIK 0001400975
ROLE
Chief Financial Officer
PRIMARY
CNTA
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001400975DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback